Clinical trials
Infertility trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 9 |
| Terminated | 3 |
| Recruiting | 3 |
| Suspended | 2 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 5 |
| Ferring Pharmaceuticals | 4 |
| Imperial College London | 4 |
| University of Nottingham | 3 |
| CARE Fertility UK | 2 |
| IBSA Institut Biochimique SA | 2 |
| King's College London | 2 |
| Vitrolife | 2 |
| Anglo Celtic Cooperative Oncology Group | 1 |
| Birmingham Women's NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility | 47 |
| Abortion, Spontaneous | 3 |
| Breast Neoplasms | 2 |
| Infertility, Female | 2 |
| Sexual Dysfunction, Physiological | 2 |
| Adenomyosis | 1 |
| Aneuploidy | 1 |
| Anovulation | 1 |
| Hyperprolactinemia | 1 |
| Hypogonadism | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.